Please login to the form below

Not currently logged in
Email:
Password:

Arquer Diagnostics appoints CEO

Nadia Whittley takes up the lead role at the oncology diagnostics firm

Arquer Diagnostics Nadia WhittleySunderland, UK-based Arquer Diagnostics has appointed Nadia Whittley as its new chief executive officer with immediate effect.

Whittley joins the oncology diagnostic specialist from Tefen Management Consulting, where she was partner and managing director, Europe, responsible for the strategic direction of the company's life science business unit across EMEA.

Previously, she has served as chief executive of Alium Medical, a UK-based global supply service, managing director of medical devices, EMEA at Allergan, and marketing director for interventional cardiology, EMEA at Boston Scientific International.

Dr Sandy Primrose, chairman of Arquer Diagnostics, said: “I would like to welcome Nadia and am delighted that we have someone with her commercial background as our new chief executive officer.

“Her experience of successfully launching new technologies across multiple regions and her knowledge of the sector make her a real asset to the business, particularly as we move forward to commercialise our MCM5-ELISA diagnostic test.”

15th December 2016

From: Sales

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
PharmiWeb Solutions

PharmiWeb Solutions creates, delivers and manages digital solutions for the pharmaceutical and healthcare segment. From digital marketing, to patient education...

Latest intelligence

Australian Flu and the dilemma of naming diseases
...
Wearables and Healthcare
What place do wearables have in affecting actual patient health outcomes and can they contribute to the NHS’s sustainability agenda? Or are they just the latest fad?...
What does a future-proof rep look like?
Businesses can no longer afford to push ahead with the traditional Key Account Management model....

Infographics